Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DW5121 (Codaewon Plus) in Acute Bronchitis
NCT07093697Phase 3Completed
- Sponsor
- Daewon Pharm
- Start
- Mar 2024
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Codaewon Plus in acute bronchitis, sponsored by Daewon Pharm. Started Mar 2024; status: completed.
02
Drugs
Codaewon Plus
03
Conditions
acute bronchitis
Beyond the preview
Go deeper on NCT07093697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07093697.